Zhengzong Huang
Biographic Data
| ID | 6589492 |
|---|---|
| NAME | Zhengzong Huang |
| GIVEN NAMES | Zhengzong |
| FAMILY NAME | Huang |
| SIGNATURE | HUANG Z |
| AFFILIATIONS | Shenzhen Technology University |
| ORCID | 0000-0002-0542-4860 |
| VERIFIED | Yes |
| TOTAL WORKS | 12 |
| TOTAL CITATIONS | 4 |
| WORKS AS AUTHOR | 12 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Optimizing China’s value-added tax preferential policies for employment of people with disabilities
Prioritising re-employment skills training for people with disabilities
Family doctor contract services for persons with disabilities in China
Legal protection of a barrier-free environment for the marriage rights of disabled individuals in China
Enhancing inclusivity on short video platforms in China
Evolutionary game model and simulation analysis of multi-stakeholder behaviour for promoting Braille labelling on pharmaceutical packaging in China’s legal framework
This study investigates the factors influencing the lack of Braille-embossed labels in Chinese pharmaceutical product packaging. To this end, this study constructs an evolutionary game model of multi-participant behaviour in drug production regulation and conducts simulation based on the perspective of stakeholders in order to study the evolutionary steady state of regulatory authorities, pharmaceutical companies, and visually impaired individual…
Administrative regulation-informed analysis of the developmental path of national volume-based procurement to improve drug accessibility in China
Introduction: The procurement of medicines via China's national volume-based procurement (NVBP) necessitates collaboration among various entities. This paper highlights the legal significance of the engagement of pharmaceutical companies, hospitals, and the National Healthcare Security Administration (NHSA) in improving drug accessibility. Methods: We conducted a numerical simulation using MATLAB to develop an evolutionary game model involving th…
Lack of braille labelling and instructions on Chinese pharmaceutical packaging
Braille labels and instructions on medicine packaging are scarce in China, impeding blind individuals' ability to obtain information about medications.Article 37 of China's Barrier-Free Environment Creation Law, enacted in September 2023, requires braille labelling and instructions for pharmaceuticals.This provision offers essential legal protection to ensure the safety of blind individuals when using medications.Nevertheless, the use of braille …
Enhancing sign language recognition and accessibility for the deaf community in China
Navigating digital financial exclusion
Unveiling false employment
Regulating the product quality of Covid-19 antigen testing reagents
Personal purchases of novel coronavirus antigen detection reagents (ADRs) for self-detection have contributed to the optimization of medical resources and containment of the COVID-19 pandemic. The recurring occurrence of false testing results in China has generated concerns regarding the quality of ADRs and the testing mechanism for medical devices. Academic viewpoints and remarks on the sensitivity, application possibilities, and product innovat…
Regulating the product quality of Covid-19 antigen testing reagents
Personal purchases of novel coronavirus antigen detection reagents (ADRs) for self-detection have contributed to the optimization of medical resources and containment of the COVID-19 pandemic. The recurring occurrence of false testing results in China has generated concerns regarding the quality of ADRs and the testing mechanism for medical devices. Academic viewpoints and remarks on the sensitivity, application possibilities, and product innovat…
Evolutionary game model and simulation analysis of multi-stakeholder behaviour for promoting Braille labelling on pharmaceutical packaging in China’s legal framework
This study investigates the factors influencing the lack of Braille-embossed labels in Chinese pharmaceutical product packaging. To this end, this study constructs an evolutionary game model of multi-participant behaviour in drug production regulation and conducts simulation based on the perspective of stakeholders in order to study the evolutionary steady state of regulatory authorities, pharmaceutical companies, and visually impaired individual…
Administrative regulation-informed analysis of the developmental path of national volume-based procurement to improve drug accessibility in China
Introduction: The procurement of medicines via China's national volume-based procurement (NVBP) necessitates collaboration among various entities. This paper highlights the legal significance of the engagement of pharmaceutical companies, hospitals, and the National Healthcare Security Administration (NHSA) in improving drug accessibility. Methods: We conducted a numerical simulation using MATLAB to develop an evolutionary game model involving th…
Lack of braille labelling and instructions on Chinese pharmaceutical packaging
Braille labels and instructions on medicine packaging are scarce in China, impeding blind individuals' ability to obtain information about medications.Article 37 of China's Barrier-Free Environment Creation Law, enacted in September 2023, requires braille labelling and instructions for pharmaceuticals.This provision offers essential legal protection to ensure the safety of blind individuals when using medications.Nevertheless, the use of braille …
Enhancing sign language recognition and accessibility for the deaf community in China
Navigating digital financial exclusion
Unveiling false employment
Optimizing China’s value-added tax preferential policies for employment of people with disabilities
Prioritising re-employment skills training for people with disabilities
Family doctor contract services for persons with disabilities in China
Legal protection of a barrier-free environment for the marriage rights of disabled individuals in China
Enhancing inclusivity on short video platforms in China
China (9 works) · Business (8 works) · Law (8 works) · Political science (8 works) · Psychology (6 works) · Law (5 works) · Economics (4 works) · Marketing (4 works) · Computer Science (3 works) · Public economics (3 works)